TCR CDR3-antigen chemical complementarity associated with poor ovarian cancer outcomes: A vestigial immune response to early cancer antigens?

导出 LinkOut

翻译打印收藏纠错

作者： Vayda R,Barker ^[1] ; Mallika,Varkhedi ^[1] ; Dhruv N,Patel ^[1] ; Monica,Hsiang ^[1] ; Andrea,Chobrutskiy ^[2] ; Boris I,Chobrutskiy ^[3] ; George,Blanck ^[1]

作者单位： Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA. ^[1] Department of Pediatrics, Oregon Health and Science University Hospital, Portland, Oregon, USA. ^[2] Department of Internal Medicine, Oregon Health and Science University Hospital, Portland, Oregon, USA. ^[3] Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. ^[4]

关键词 MAGEB4 TDRD1 TRA and TRB recombination chemical complementarity scoring disease free survival ovarian cancer

主题词人类(Humans);女(雌)性(Female);互补决定区(Complementarity Determining Regions);卵巢肿瘤(Ovarian Neoplasms);免疫(Immunity)

DOI 10.1111/aji.13639

PMID 36317868

发布时间 2023-02-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交